First treatment for serious chronic lung disease

EMA has recommended granting a marketing authorisation in the European Union (EU) for Brinsupri (brensocatib) 25 mg tablets, for the treatment of non-cystic fibrosis…

Leave a Reply

Your email address will not be published. Required fields are marked *